Raab & Moskowitz Asset Management LLC Sells 200 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Raab & Moskowitz Asset Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 7,723 shares of the healthcare conglomerate’s stock after selling 200 shares during the quarter. UnitedHealth Group makes up 1.0% of Raab & Moskowitz Asset Management LLC’s investment portfolio, making the stock its 26th largest position. Raab & Moskowitz Asset Management LLC’s holdings in UnitedHealth Group were worth $3,907,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. McClarren Financial Advisors Inc. raised its holdings in UnitedHealth Group by 62.7% during the 4th quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock valued at $775,000 after acquiring an additional 591 shares during the period. Hidden Cove Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $214,000. Naples Global Advisors LLC boosted its stake in UnitedHealth Group by 3.0% in the 4th quarter. Naples Global Advisors LLC now owns 14,468 shares of the healthcare conglomerate’s stock worth $7,319,000 after purchasing an additional 428 shares during the period. Van ECK Associates Corp increased its position in shares of UnitedHealth Group by 12.6% during the fourth quarter. Van ECK Associates Corp now owns 196,907 shares of the healthcare conglomerate’s stock valued at $99,607,000 after buying an additional 22,059 shares during the period. Finally, Retirement Guys Formula LLC boosted its position in shares of UnitedHealth Group by 1.0% in the fourth quarter. Retirement Guys Formula LLC now owns 4,096 shares of the healthcare conglomerate’s stock valued at $2,072,000 after acquiring an additional 41 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $527.31 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business has a 50 day moving average price of $526.25 and a 200-day moving average price of $563.96. The firm has a market cap of $485.27 billion, a PE ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 earnings per share. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on UNH shares. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.